Financial Statements IHH Healthcare Berhad is a company incorporated and domiciled in Malaysia. It is listed on Bursa Malaysia Securities Berhad and Singapore Exchange Securities Trading Limited. The address of the Company’s principal place of business and registered office is as follows: Level 11, Block A Pantai Hospital Kuala Lumpur 8 Jalan Bukit Pantai 59100 Kuala Lumpur The consolidated financial statements of the Company as at and for the financial year ended 31 December 2023 comprise the Company and its subsidiaries (together referred to as the “Group” or “IHH Group” and individually referred to as “Group entities”) and the Group’s interests in associates and joint ventures. The principal activities of the Company are those relating to investment holding and the provision of consultancy and support services, whilst the principal activities of the subsidiaries are as stated in note 41 to the financial statements. There has been no significant change in the nature of these activities during the financial year. These financial statements were authorised for issue by the Board of Directors on 29 February 2024. 1. BASIS OF PREPARATION (a) Statement of compliance The financial statements of the Group and of the Company have been prepared in accordance with Malaysian Financial Reporting Standards (“MFRSs”), IFRS Accounting Standards as issued by the International Accounting Standards Board (“IFRS Accounting Standards”) and the requirements of the Companies Act 2016 in Malaysia. The following are accounting standards, interpretations and amendments of the MFRSs that have been issued by the Malaysian Accounting Standards Board (“MASB”) but have not been adopted by the Group and the Company: MFRSs, interpretations and amendments effective for annual periods beginning on or after 1 January 2024 • Amendments to MFRS 16, Leases – Lease Liability in a Sale and Leaseback • Amendments to MFRS 101, Presentation of Financial Statements – Non-current Liabilities with Covenants and Classification of Liabilities as Current or Non-current • Amendments to MFRS 107, Statement of Cash Flows and MFRS 7, Financial Instruments: Disclosures – Supplier Finance Arrangements MFRSs, interpretations and amendments effective for annual periods beginning on or after 1 January 2025 • Amendments to MFRS 121, The Effects of Changes in Foreign Exchange Rates – Lack of Exchangeability MFRSs, interpretations and amendments effective for annual periods beginning on or after a date yet to be confirmed • Amendments to MFRS 10, Consolidated Financial Statements and MFRS 128, Investments in Associates and Joint Ventures – Sale or Contribution of Assets between an Investor and its Associate or Joint Venture The Group and the Company plan to apply the abovementioned amendments: • from the annual period beginning on 1 January 2024 for the amendments that are effective for annual periods beginning on or after 1 January 2024. • from the annual period beginning on 1 January 2025 for the amendment that is effective for annual periods beginning on or after 1 January 2025. The initial application of the abovementioned amendments is not expected to have any material financial impacts to the current period and prior period financial statements of the Group and of the Company. Notes to the Financial Statements IHH Healthcare Berhad 148
RkJQdWJsaXNoZXIy NDgzMzc=